El Hospital del Mar, es un centro sanitario general moderno, universitario, activo, investigador, que atiende patologías de complejidad media y alta situado en el Paseo Marítimo de Barcelona. Fue inaugurado en el año 1905, siendo uno de los hospitales más importantes de Barcelona.

During the past decade, Hospital de Mar conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Mar" #1 sponsor was "Merck Sharp & Dohme LLC" with 3 trials, followed by "AB Biotics, SA" with 1 trials sponsored, "Grupo Español de Tratamiento de Tumores de Cabeza y Cuello" with 1 trials sponsored, "Grupo Español de Tumores Huérfanos e Infrecuentes" with 1 trials sponsored and "LifeCell" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Mar" #1 collaborator was "Apices Soluciones S.L." with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Global Research Solutions" with 1 trials as a collaborator, "Innovative Medicines Initiative (IMI) COMBACTE-CARE" with 1 trials as a collaborator and "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Mar" are "Prostatic Neoplasms" (3 trials), "Complicated Intra-Abdominal Infections, cIAIs" (1 trials), "Degenerative Lesion of Articular Cartilage of Knee" (1 trials), "Depressive Disorder, Major" (1 trials) and "Hernia" (1 trials). Many other conditions were trialed in "Hospital de Mar" in a lesser frequency.

Most popular intervention types in "Hospital de Mar" are "Drug" (7 trials), "Biological" (3 trials), "Device" (2 trials), "Procedure" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (3 trials), "Enzalutamide" (2 trials), "Placebo" (2 trials), "Prednisone" (2 trials) and "ATM-AVI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Mar" are 5 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital de Mar". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital de Mar, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Mar, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".